Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI
National Science Review · 03.04.2024 · 11 (5)
DOI: 10.1093/nsr/nwae057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift National Science Review, online erschienen am 07.02.2024. Verfasst von Guangxiang Si und 12 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210009, Chin…. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Nanjing Science and Technology Development Foundation.
Abstract (Originalsprache)
Contrast-enhanced magnetic resonance imaging (CE-MRI) is a pivotal tool for global disease diagnosis and management. Since its clinical availability in 2009, the off-label use of ferumoxytol for ferumoxytol-enhanced MRI (FE-MRI) has significantly reshaped CE-MRI practices. Unlike MRI that is enhanced by gadolinium-based contrast agents, FE-MRI offers advantages such as reduced contrast agent dosage, extended imaging windows, no nephrotoxicity, higher MRI time efficiency and the capability for molecular imaging. As a leading superparamagnetic iron oxide contrast agent, ferumoxytol is heralded as the next generation of contrast agents. This review delineates the pivotal clinical applications and inherent technical superiority of FE-MRI, providing an avant-garde medical-engineering interdisciplinary lens, thus bridging the gap between clinical demands and engineering innovations. Concurrently, we spotlight the emerging imaging themes and new technical breakthroughs. Lastly, we share our own insights on the potential trajectory of FE-MRI, shedding light on its future within the medical imaging realm.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210009, China.
- Key Laboratory for Bio-Electromagnetic Environment and Advanced Medical Theranostics, School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 210029, China.
- Department of Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- MR Collaboration, Siemens Healthineers Ltd., Shanghai 200126, China.
- Department of Radiology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
- School of Mathematical Sciences, Capital Normal University, Beijing 100048, China.
ORCID-Profile: Ning Gu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Nanjing Science and Technology Development Foundation
Zitieren
APA
Si, G., Du, Y., Tang, P., Ma, G., Jia, Z., Zhou, X., Mu, D., Shen, Y., Lu, Y., Mao, Y., Chen, C., Li, Y., & Gu, N. (2024). Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI. National Science Review, 11(5). https://doi.org/10.1093/nsr/nwae057
Vancouver
Si G, Du Y, Tang P, Ma G, Jia Z, Zhou X, et al. Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI. National Science Review. 2024;11(5). doi:10.1093/nsr/nwae057
BibTeX
@article{Si2024,
author = {Si, Guangxiang and Du, Yue and Tang, Peng and Ma, Gao and Jia, Zhaochen and Zhou, Xiaoyue and Mu, Dan and Shen, Yan and Lu, Yi and Mao, Yu and Chen, Chuan and Li, Yan and Gu, Ning},
title = {Unveiling the next generation of MRI contrast agents: current insights and perspectives on ferumoxytol-enhanced MRI},
journal = {National Science Review},
year = {2024},
volume = {11},
number = {5},
doi = {10.1093/nsr/nwae057}
}
EUVIMED